drugset / Trial / NCT03063437
A Trial of Encapsulated Fecal Microbiota for Vancomycin Resistant Enterococcus Decolonization
Phase 2
Completed
9 enrolled
Microbiome Health Research Institute
Indiana University · collabUniversity of Wisconsin, Madison · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The objective of this study is to provide preliminary insight into the safety and efficacy of fecal microbiota transplantation (FMT) for the eradication of gastrointestinal carriage of vancomycin-resistant Enterococcus.
Timeline
- Start
- 2017-08-17
- Primary completion
- 2018-09-19
- Completion
- 2019-02-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Encapsulated fecal microbiota preparation | Unknown | 30 unknown | Oral |
Indications
No indication recorded.